Ann: Half Year Accounts 31 December 2023, page-2

This board/management has delivered nothing of consequence

.Padding along with soft-going nowhere collaborations.

The FDA approval is the first hurdle, then if achieved, do they have the capacity to commercialize the technology?

They had massive momentum and the follow-through has been pathetic.

The end of March and beyond will indicate whether or not this is just another group of car sale "opportunists" or a professional board and management group that can convert a concept into reality.

The lot of them seem to have gone asleep at the wheel.